Tucker Sean 4

What Happened
Sean Tucker, Senior Vice President and Chief Scientific Officer of Vaxart, had 36,418 shares withheld by the company to satisfy income tax withholding on vested restricted stock units (RSUs). The net settlement value was $0.69 per share, totaling approximately $25,274. This transaction is a tax-withholding/net-settlement (code F), not an open-market sale.

Key Details

• Transaction date: March 24, 2026
• Price per share: $0.69
• Shares withheld/disposed: 36,418
• Reported value: ~$25,274
• Shares owned after transaction: not specified in the provided filing
• Footnote: F1 — shares were withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 24, 2026
• Filing date: March 26, 2026 (covers the 3/24 transaction) — appears timely based on the report dates

Context
This was a routine net settlement to cover taxes on vested RSUs (shares withheld by the company), not an active open-market sale. Such withholding transactions are administrative and don’t necessarily indicate insider sentiment about the company’s stock. Purchases or open-market sales generally carry more signal for investors than tax-withholding dispositions.